首页|期刊导航|中药与临床|中国-东盟共有热带药用植物白花蛇舌草的研究进展

中国-东盟共有热带药用植物白花蛇舌草的研究进展OA

Research progress on Hedyotis diffusa Willd.,a tropical medicinal plant shared by China and ASEAN

中文摘要英文摘要

白花蛇舌草是中国热带地区与东盟国家共有且具有代表性的药用植物资源,兼具清热解毒的传统药用价值与保健茶饮的民间应用基础,具有"药食兼用"的特点.本文系统梳理了白花蛇舌草的资源现状、传统应用知识、现代化学成分、药理作用及质量控制方面的研究进展,同时对其商贸及产品开发情况进行了分析.文章指出,尽管白花蛇舌草目前已开展较多研究,但仍存在部分成分机制不明确、质量标准不统一、资源可持续性不足等问题,未来可依托"一带一路"区域合作框架,加强多学科交叉与资源互补,为推动该类区域共有热带药用植物资源的可持续利用与国际化发展提供参考.

Hedyotis diffusa Willd.is a representative medicinal plant resource shared by tropical regions of China and ASEAN countries.It possesses both the traditional medicinal value of clearing heat and detoxifying,as well as a foundation for folk applications in healthcare teas,exhibiting characteristics of"medicinal and edible uses".This paper systematically reviews the research progress on the resource status,traditional application knowledge,modern chemical composition,pharmacological ef-fects,and quality control of Hedyotis diffusa Willd.,while also analyzing its commercial trade and product development.The ar-ticle points out that although considerable research has been conducted on Hedyotis diffusa Willd.,issues such as unclear mecha-nisms of certain components,inconsistent quality standards,and insufficient resource sustainability persist.In the future,leverag-ing the regional cooperation framework of the"Belt and Road"Initiative,interdisciplinary collaboration and resource complemen-tarity can be strengthened to provide references for promoting the sustainable utilization and international development of such shared tropical medicinal plant resources in the region.

张吴艳;楚圆圆;Leu Kim Fey;陈鸿平;张三印;徐彬杰

成都中医药大学中医药创新研究院/交叉学科研究院,四川成都 611137||成都中医药大学药学院,四川成都 611137成都中医药大学中医药创新研究院/交叉学科研究院,四川成都 611137||成都中医药大学药学院,四川成都 611137拉曼大学M Kandiah医学与健康科学学院,马来西亚雪兰莪州加影,43000成都中医药大学药学院,四川成都 611137成都中医药大学中医药创新研究院/交叉学科研究院,四川成都 611137成都中医药大学中医药创新研究院/交叉学科研究院,四川成都 611137

医药卫生

热带药用植物白花蛇舌草传统应用质量控制区域合作

Tropical medicinal plantsHedyotis diffusa Willd.traditional applicationquality controlregional cooperation

《中药与临床》 2026 (2)

57-62,70,7

[项目编号]成都中医药大学"杏林学者"项目(YJ2025001)

评论